Stem cell therapy for stable coronary artery disease
Part of Heart & circulation clinical trials.
This trial tests a new stem cell treatment (HeXell-2020) for people with stable coronary artery disease. It aims to see if it's safe and can improve heart function. You may be eligible if you have stable angina and are on regular heart medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 75 years old.
- You must have stable coronary artery disease with at least one blocked artery (50% or more) seen on a heart imaging test in the past year.
- You must have stable angina (chest pain with activity) and be on steady heart medications for at least 4 weeks.
- You cannot have a blood clot in your heart or a ventricular aneurysm (a bulging heart wall).
- You must not have had a heart attack, stroke, or major heart surgery in the past 90 days.
- You must not be pregnant, and if you can have children, must use effective birth control during the study and for 4 weeks after.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 study tests whether an “MCRcI” stem cell treatment is safe and may improve symptoms in people with widespread coronary artery disease (clogged heart arteries). It may help those with ongoing chest pain from angina despite proper heart medications.
This trial tests a new gene therapy (XC001) delivered through a thin tube into your heart's blood vessels. It aims to grow new blood vessels to relieve chest pain in people with chronic angina who have no other treatment options.
This trial is testing a device called SONICURE to help open up stents that haven't expanded fully inside a heart artery. It is for people with heart disease who are having a procedure to treat a narrowed or blocked artery.
This trial tests whether an inhaled medication called Aroxxen® can protect your heart during a planned stent procedure. It may help reduce stress on the heart muscle.
This study follows people who need a coronary (heart) stent to see how they do after treatment. It does not sound like an experimental drug trial for you—it’s mainly about collecting health information after a stent procedure.
This Phase 2 trial tests whether stem cells placed into the heart artery can safely reduce symptoms in people with “refractory” angina (chest pain) despite maximum heart-healthy medication. You may qualify if your chest pain is limiting your activity and other heart procedures (stents/bypass) aren’t possible or are too risky.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.